All Articles

The authors report on the use of technology to reduce the administrative burden of tumor boards while improving the quality of care delivered.
Read More



No matter who you are, cancer is frightening, complicated, and overwhelming, according to Jill Biden, EdD, lifelong educator, former Second Lady of the United States, and cofounder of the Biden Cancer Initiative.
Read More

  • FDA Approves First Therapy for the Treatment of Adult Patients with a Rare Blood Clotting Disorder
  • FDA Issues Letter to Healthcare Providers Alerting Them to a Risk for Breast Implant Associated–Anaplastic Large-Cell Lymphoma
Read More

  • FDA Resumes Operations After Government Shutdown Ends
  • FDA Approves New Drug Indication for Use in Hepatocellular Carcinoma
  • FDA Approves Pembrolizumab for Merkel-Cell Carcinoma
Read More

Now in its fourth week, the longest shutdown in the history of the federal government is having an impact on patient care, as the US Food and Drug Administration (FDA) has put drug reviews and approvals for new drugs and devices, as well as the issuance of new guidance documents, on indefinite hold.
Read More

Carsten Kampe, MD, PhD, discusses the excitement surrounding immunotherapy at the AONN+ Annual Conference
Read More

An exploration of the challenges confronting older patients with Acute Myeloid Leukemia and their healthcare providers.
Read More

Navigation can have a positive impact on the patient experience and a positive economic impact for organizations.
Read More

Page 184 of 283

Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country